Ridinilazole
Ridinilazole is a novel antibacterial with MICs range of 0.06-0.25 μg/mL (MIC90=8 μg/mL) against C. difficile.
Product Specifications
CAS Number
308362-25-6
Product Name Alternative
SMT19969
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/Ridinilazole.html
Purity
99.02
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 80°C)
Smiles
C1(C2=CC=NC=C2)=NC3=CC(C4=CC=C5C(N=C(C6=CC=NC=C6)N5)=C4)=CC=C3N1
Molecular Formula
C24H16N6
Molecular Weight
388.42
Precautions
H302, H315, H319, H335
References & Citations
[1]Vickers RJ, et al. Ridinilazole: a novel therapy for Clostridium difficile infection. Int J Antimicrob Agents. 2016 Aug;48 (2) :137-43.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ICH1124-5mg 5 mg
Anti-Mouse IFN Beta (MIB-5E9.1) In Vivo Antibody - Low Endotoxin
Sign In for Pricing
View Details 
